Investigations on the 4‐Quinolone‐3‐Carboxylic Acid Motif Part 5: Modulation of the Physicochemical Profile of a Set of Potent and Selective Cannabinoid‐2 Receptor Ligands through a Bioisosteric Approach

Citations Over TimeTop 11% of 2012 papers

Abstract

Three heterocyclic systems were selected as potential bioisosteres of the amide linker for a series of 1,6-disubstituted-4-quinolone-3-carboxamides, which are potent and selective CB2 ligands that exhibit poor water solubility, with the aim of improving their physicochemical profile and also of clarifying properties of importance for amide bond mimicry. Among the newly synthesized compounds, a 1,2,3-triazole derivative (1-(adamantan-1-yl)-4-[6-(furan-2-yl)-1,4-dihydro-4-oxo-1-pentylquinolin-3-yl]-1H-1,2,3-triazole) emerged as the most promising in terms of both physicochemical and pharmacodynamic properties. When assayed in vitro, this derivative exhibited inverse agonist activity, whereas, in the formalin test in mice, it produced analgesic effects antagonized by a well-established inverse agonist. Metabolic studies allowed the identification of a side chain hydroxylated derivative as its only metabolite, which, in its racemic form, still showed appreciable CB2 selectivity, but was 150-fold less potent than the parent compound.

Related Papers

• → Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor ‘silent antagonist’(2005)66 cited
• → Synthesis and Activity of 1,3,5-Triphenylimidazolidine-2,4-diones and 1,3,5-Triphenyl-2-thioxoimidazolidin-4-ones: Characterization of New CB₁ Cannabinoid Receptor Inverse Agonists/Antagonists(2006)47 cited
• → Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB1 receptor antagonist(2010)32 cited
• → Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist(2015)21 cited
• → Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists(2011)3 cited